Chicago, Illinois-based Abbott Laboratories introduced a new cardiac test in India. The company said that this test can detect very low levels of troponin and can be used to determine cardiac risk in people with no reported symptoms of heart disease, providing better predictive information for determining a person’s chances of developing future heart disease when added to the current standard of care.
“As we launch our test on World Heart Day [September 29], Abbott will work with physicians and laboratories in India to determine how this could fit within their existing practices for prevention or annual health check-ups,” said Narendra Varde, general manager and country head at Abbott’s Diagnostics Business.
